title: Oxygen uptake kinetics during heavy submaximal exercise: Effect of sickle cell trait with or without alpha-thalassemia.
abstract: Sickle cell trait (SCT) is a genetic disease affecting the synthesis of normal hemoglobin (Hb) marked by the heterozygous presence of HbA and HbS. It is thought that exercise tolerance and aerobic capacity could be limited in SCT carriers, but that the co-existence of alpha-thalassemia with SCT (SCTAT) could improve exercise response. To examine these issues, we compared the characteristics of VO2 kinetics during a constant heavy exercise among athletes carrying either the SCT (n = 6), the SCTAT (n = 9), or the normal Hb (control group; n = 10). After determination of maximal power output (Ppeak), all subjects underwent a constant heavy cycling exercise lasting 9 min at approximately 70 % Ppeak. Pulmonary VO2 and cardio-respiratory parameters were measured breath-by-breath and the VO2 response was modelled using non-linear regression techniques. The time constant of the VO2 primary component and oxygen deficit were not significantly different among the three groups. The VO2 slow component was 28 % and 33 % higher (p < 0.05) in SCT and SCTAT than in the control groups, respectively. Altogether, athletes with the SCT and the SCTAT had higher heart rate at the beginning (+ 5.2 %) and the end (+ 7.4 %) of the slow component compared to the control group (p < 0.05). These results suggest that SCT and SCTAT subjects are not limited during the first exercise minutes, but are prone to exercise intolerance and to lower aerobic capacity thereafter, due to a higher VO2 slow component, and that alpha-thalassemia does not improve exercise response. The finding of a higher slow component in SCT and SCTAT athletes was possibly due to the loss of O2 availability to muscles, additional fiber recruitment and/or higher cardiac load with time.
authors.affiliation: EA 647 Centre de Recherche et d'Innovation sur le Sport, Université Claude Bernard Lyon 1, Villeurbanne, France. pconnes@yahoo.fr
authors.forename: P
authors.initials: P
authors.lastname: Connes
authors.forename: G
authors.initials: G
authors.lastname: Monchanin
authors.forename: S
authors.initials: S
authors.lastname: Perrey
authors.forename: D
authors.initials: D
authors.lastname: Wouassi
authors.forename: G
authors.initials: G
authors.lastname: Atchou
authors.forename: A
authors.initials: A
authors.lastname: Forsuh
authors.forename: J
authors.initials: J
authors.lastname: Debaud
authors.forename: B
authors.initials: B
authors.lastname: Djoda
authors.forename: F-X
authors.initials: FX
authors.lastname: Owona
authors.forename: A
authors.initials: A
authors.lastname: Francina
authors.forename: P E
authors.initials: PE
authors.lastname: Banga
authors.forename: R
authors.initials: R
authors.lastname: Massarelli
authors.forename: P
authors.initials: P
authors.lastname: Thiriet
authors.forename: C
authors.initials: C
authors.lastname: Martin
mesh_terms: D000328:Adult; D000704:Analysis of Variance; D016022:Case-Control Studies; D015444:Exercise / Q000502:physiology*; D006339:Heart Rate / Q000502:physiology; D006801:Humans; D007773:Lactates / Q000097:blood; D008297:Male; D010101:Oxygen Consumption / Q000502:physiology*; D010807:Physical Endurance / Q000502:physiology; D012044:Regression Analysis; D012805:Sickle Cell Trait / Q000503:physiopathology*; D013177:Sports; D017085:alpha-Thalassemia / Q000503:physiopathology*
chemical_list: D007773:Lactates